Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUAK1 | O60285 | 1/20 | 0.68 |
| ▸ | NTRK1 | P04629 | 16/20 | 0.60 |
| ▸ | IGF1R | P08069 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3127072 | 1.00 | NUAK1 (0.68) | NUAK1NTRK1IGF1R | |
| SCHEMBL3126574 | 0.92 | NUAK1 (0.56) | NUAK1NTRK1 | |
| SCHEMBL3126595 | 0.92 | NUAK1 (0.56) | NUAK1NTRK1 | |
| SCHEMBL3124301 | 0.87 | NUAK1 (0.68) | NUAK1NTRK1IGF1R | |
| SCHEMBL3124294 | 0.87 | NUAK1 (0.68) | NUAK1NTRK1IGF1R | |
| SCHEMBL3124443 | 0.86 | NTRK1 (0.51) | NUAK1NTRK1 | |
| SCHEMBL3124459 | 0.86 | NTRK1 (0.51) | NUAK1NTRK1 | |
| SCHEMBL3132279 | 0.86 | NTRK1 (0.50) | NUAK1NTRK1 | |
| SCHEMBL3132267 | 0.86 | NTRK1 (0.50) | NUAK1NTRK1 | |
| SCHEMBL3134973 | 0.85 | NTRK1 (0.55) | NUAK1NTRK1IGF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3458464-B1 | STEREOSELECTIVE SYNTHESIS OF PHOSPHOROTHIOATE OLIGORIBONUCLEOTIDES | ETH ZUERICH (CH) | 2026-04-15 | — | — | EP | claimed |
| EP-3980554-B1 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | HOFFMANN LA ROCHE (CH) | 2025-03-26 | — | — | EP | claimed |
| EP-3884055-B1 | DOUBLE AND INDUCIBLE SUICIDE GENE CONSTRUCT AND ITS USE IN GENE THERAPY | CONSEJO SUPERIOR INVESTIGACION (ES) | 2023-08-09 | — | — | EP | claimed |
| EP-3199165-B1 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF KRAS BY ASYMMETRIC DOUBLE-STRANDED RNA | DICERNA PHARMACEUTICALS INC (US) | 2022-06-08 | — | — | EP | claimed |
| EP-2514758-B2 | Methods and compositions for the specific inhibition of gene expression by double-stranded RNA | HOPE CITY (US) | 2021-06-23 | — | — | EP | claimed |
| EP-3087184-B1 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GLYCOLATE OXIDASE (HAO1) BY DOUBLE-STRANDED RNA | DICERNA PHARMACEUTICALS INC (US) | 2019-07-03 | — | — | EP | claimed |
| EP-3218488-B1 | ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING | Neurovision Pharma GmbH (DE) | 2018-10-24 | — | — | EP | claimed |
| EP-1742958-B1 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA | HOPE CITY (US) | 2017-05-17 | — | — | EP | claimed |
| EP-2514758-B1 | Methods and compositions for the specific inhibition of gene expression by double-stranded RNA | HOPE CITY (US) | 2017-04-19 | — | — | EP | claimed |
| EP-2756845-B1 | Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA | DICERNA PHARMACEUTICALS INC (US) | 2017-03-15 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0673783-B1 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORP (US) | 2000-07-05 | — | — | EP | claimed |
| EP-0719271-B1 | 5-(1-FLUORO-VINYL)-1H-PYRIMIDINE-2,4-DIONE DERIVATIVES USEFUL AS ANTINEOPLASTIC AGENTS | MERRELL PHARMA INC (US) | 1997-11-26 | — | — | EP | claimed |
| EP-0398231-B1 | Nucleoside analogs | ACAD OF SCIENCE CZECH REPUBLIC (CZ) | 1997-07-16 | — | — | EP | claimed |
| EP-0630381-B1 | ANTIVIRAL ACYCLIC PHOSPHONOMETHOXYALKYL SUBSTITUTED, ALKENYL AND ALKYNYL PURINE AND PYRIMIDINE DERIVATIVES | ACAD OF SCIENCE CZECH REPUBLIC (CZ) | 1997-04-09 | — | — | EP | claimed |
| EP-0540686-B1 | 2'-FLUOROFURANOSYL DERIVATIVES AND NOVEL METHOD OF PREPARING 2'-FLUOROPYRIMIDINE AND 2'-FLUOROPURINE NUCLEOSIDES | US COMMERCE (US) | 1995-08-30 | — | — | EP | claimed |
| EP-0494370-B1 | Antiviral (phosphonomethoxy)methoxy purine/pyrimidine derivatives | ACAD OF SCIENCE CZECH REPUBLIC (CS) | 1995-06-28 | — | — | EP | claimed |
| EP-0272446-B1 | NOVEL ANTIVIRAL AGENTS | SRI INTERNATIONAL (US) | 1992-11-11 | — | — | EP | claimed |
| EP-0506935-A1 | NOVEL RIBONUCLEOSIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND DRUGS CONTAINING SAID COMPOUNDS | PASTEUR MERIEUX SERUMS ET VACCINS, Société Anonyme : (FR) | 1992-10-07 | — | — | EP | claimed |
| WO-1992006993-A1 | NOVEL RIBONUCLEOSIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND DRUGS CONTAINING SAID COMPOUNDS | PASTEUR MERIEUX SERUMS ET VACCINS (FR) | 1992-04-30 | — | — | WO | claimed |